drugset / Trial / NCT03297489

Intravital Microscopy in Evaluating Patients With Primary Peritoneal, Fallopian Tube, or Stage IA-IV Ovarian Cancer

NCT03297489

Phase 0 Completed 19 enrolled Roswell Park Cancer Institute
NaSingle-groupOpen-labelDiagnostic

Summary

This pilot clinical trial studies how well intravital microscopy works in evaluating patients with primary peritoneal, fallopian tube, or stage IA-IV ovarian cancer. Intravital microscopic evaluation of tumor blood vessels, blood flow, immune cell interactions, and drug uptake may be eventually visualized and may lead to valuable prognostic information.

Timeline

Start
2017-11-06
Primary completion
2021-02-15
Completion
2021-02-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluorescein Diagnostic / imaging agent Intravenous